Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001
Clinical trial NCT07264569 · RECRUITING
Trial details
- NCT number
- NCT07264569
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-12-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.